We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab.
- Authors
van der Veer, Tjeerd; Dallinga, Marloes A.; van der Valk, Johanna P. M.; Kappen, Jasper H.; in 't Veen, Johannes C. C. M.; van der Eerden, Menno M.; Braunstahl, Gert‐Jan
- Abstract
Five patients had a strong reduction in total serum IgE, while follow-up measurements of serum IgE were not available for the other three patients. Keywords: ABPA; allergic bronchopulmonary aspergillosis; asthma; dupilumab; allergische bronchopulmonale aspergillose; asma; Aspergilosis broncopulmonar alérgica EN ABPA allergic bronchopulmonary aspergillosis asthma dupilumab allergische bronchopulmonale aspergillose asma Aspergilosis broncopulmonar alérgica 1 3 3 12/29/21 20211201 NES 211201 To the Editor,Allergic bronchopulmonary aspergillosis (ABPA) is a difficult-to-treat disease caused by airway inflammation triggered by an excessive allergic response to inhaled fungal spores.
- Subjects
DUPILUMAB; ASTHMATICS; ASPERGILLOSIS; EOSINOPHILIA; WHEEZE; DISEASE exacerbation; PULMONARY aspergillosis; PREDNISONE
- Publication
Clinical & Translational Allergy, 2021, Vol 11, Issue 10, p1
- ISSN
2045-7022
- Publication type
Article
- DOI
10.1002/clt2.12081